Krka, d. d.
KRK
Κατάταξη σε μετοχές
#2157
Krka, d. d. is a leading generic pharmaceutical enterprise primarily involved... Krka, d. d. is a leading generic pharmaceutical enterprise primarily involved in the research, production, promotion, and sale of various pharmaceutical goods. Its market presence spans Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and numerous other international territories. The company's offerings are categorized into prescription medications, over-the-counter products, and veterinary health solutions. Its prescription drug pipeline targets a broad spectrum of medical conditions, including cardiovascular disorders, gastrointestinal issues, central nervous system ailments, pain management, anti-infective treatments, conditions affecting blood and blood-forming organs, urological problems, diabetes, and oncology. The array of non-prescription items includes products for oral and throat care, cough and cold remedies, analgesics, nasal preparations, vitamin and mineral supplements, products designed to enhance cerebral and peripheral circulation, digestive aids, and various general healthcare products. Furthermore, Krka supplies animal health products such as anti-infectives, antiparasitics, and other specialized formulations for both livestock and companion animals. Beyond its pharmaceutical operations, the company also provides health resort and tourist services. Krka, d. d. was established in 1954 and has its corporate headquarters in Novo Mesto, Slovenia.
Τιμή μετοχής
$313.05
Τελευταίος συγχρονισμός: 2026-10-19
Κεφαλαιοποίηση
$9.48B
Αλλαγή (1 ημέρα)
-1.77%
Αλλαγή (1 έτος)
30.64%
Χώρα
SI
Εμπόριο Krka, d. d. (KRK)
Κατηγορία
Healthcare
EPS για Krka, d. d. (KRK)
EPS στις June 2026 TTM: $16.04
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή της μετοχής της Krka, d. d., το τρέχον EPS της εταιρείας (TTM) είναι $16.04. Στο τέλος του 2023, η εταιρεία είχε EPS $11.21, μείωση σε σύγκριση με το EPS του 2022 που ήταν $12.54.
Ιστορικό EPS της Krka, d. d. από 2010 έως 2026
EPS στο τέλος κάθε έτους
| Έτος | EPS | Αλλαγή |
|---|---|---|
| 2026 (TTM) | $16.04 | 32.86% |
| 2024 | $12.07 | 7.68% |
| 2023 | $11.21 | -10.61% |
| 2022 | $12.54 | 11.16% |
| 2021 | $11.28 | -0.08% |
| 2020 | $11.29 | 30.17% |
| 2019 | $8.67 | 38.23% |
| 2018 | $6.27 | 10.32% |
| 2017 | $5.69 | 61.36% |
| 2016 | $3.52 | -33.21% |
| 2015 | $5.28 | -13.98% |
| 2014 | $6.13 | -14.87% |
| 2013 | $7.21 | 13.81% |
| 2012 | $6.33 | 0.85% |
| 2011 | $6.28 | -7.19% |
| 2010 | $6.77 | 0.00% |
EPS για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | EPS | Διαφορά EPS | Χώρα |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -96.53% |
IN
|
